BSE · 527005
Shree Pacetronix Ltd.
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹5 Cr with net profit ₹1 Cr — a 15.51% net margin, versus 18.06% the period before.
Shareholding
As of 2026-06-30
- Promoter36.44%
- Public63.56%
6,615 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 3.15× from low to high.
Risk flags
Derived from disclosed data
No flags raised by the data.
Peer comparison
Healthcare · ranked #43 of 85 by market cap · medians across 49 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Apollo Hospitals Enter. Limited | ₹1,30,398 Cr | 61.98 | 13.75 | 20.48% | 7.91% |
| Max Healthcare Institute Ltd. | ₹1,03,161 Cr | 68.91 | 9.6 | 13.42% | 16.73% |
| Manipal Health Enterpri Limited | ₹1,00,094 Cr | 106.73 | 6.09 | 10.59% | 7.81% |
| Fortis Healthcare Ltd. | ₹67,493 Cr | 63.27 | 6.82 | 10.53% | 11.02% |
| Aster DM Quality Care Ltd. | ₹66,295 Cr | 170.91 | 15.76 | 8.48% | 6.54% |
| Global Health Limited | ₹40,226 Cr | 70.27 | 10.15 | 14.05% | 11.88% |
| Narayana Hrudayalaya Ltd. | ₹39,223 Cr | 45.5 | 8.64 | 17.76% | 9% |
| Krishna Institute of Medical Sciences Ltd. | ₹33,519 Cr | 160.57 | 8.94 | 10.74% | 4.85% |
| Dr. Lal Path Labs Ltd. | ₹32,299 Cr | 57.42 | 12.88 | 20.13% | 18.75% |
| Poly Medicure Ltd. | ₹17,504 Cr | 54.7 | 5.64 | 10.37% | 15.77% |
| Shree Pacetronix Ltd.(this company) | ₹70 Cr | 21.53 | 3.91 | 17.36% | 15.29% |
AI analysis
AI-generated · google/gemini-2.5-flashShree Pacetronix Ltd. has a market capitalization of Rs 53 Cr. The company's EPS is Rs 8.38, with a RoE of 17.36% and RoCE of 22.18%. The debt-to-equity ratio stands at 0.35, and the profit margin is 14.52%.
Positives
- +The Return on Capital Employed (ROCE) is 22.18%.
- +Return on Equity (ROE) is 17.36%.
- +The company's profit margin is 14.52%.
Negatives
- −Promoter holding of 31.6966% is relatively low.
- −A portion of promoter shares, 10.85% of total shares, are pledged.
- −The company has not disclosed annual revenue and profit figures for a comprehensive period, with only one annual report (Mar 2025) provided in the data.
- −No quarterly results have been disclosed since March 2026.
Financial performance
For the year ending March 2025, Shree Pacetronix Ltd. reported revenue of Rs 16.92 Cr and a net profit of Rs 0.75 Cr, resulting in an EPS of Rs 2.08. Quarterly revenue for March 2026 was Rs 5.37 Cr with a net profit of Rs 1.11 Cr. The December 2025 quarter saw revenue of Rs 4.33 Cr and a net profit of Rs 0.06 Cr.
Profitability & returns
The company recorded a profit margin of 14.52%. Return on Equity (ROE) is 17.36%, while Return on Capital Employed (ROCE) is 22.18%. The Earnings Per Share (EPS) for Shree Pacetronix Ltd. is Rs 8.38.
Balance sheet
Shree Pacetronix Ltd. has a debt-to-equity ratio of 0.35, indicating a moderate level of debt. The book value per share is Rs 47.5.
Ownership & pledges
As of March 31, 2026, promoters held 31.6966% of the company's shares. Public shareholding was 68.3034%. A portion of the promoter's holding was pledged, with 10.85% of total shares (or 128,965 shares) pledged by Atul Kumar Sethi as of March 31, 2026.
Data as of — price: 2026-09-23 · financials: Jun 26 · shareholding: Jun 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.